This company has been marked as potentially delisted and may not be actively trading. Viracta Therapeutics (VIRX) Institutional Ownership Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsHeadlinesInsider TradesOwnershipShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Viracta Therapeutics (NASDAQ:VIRX)CurrentInstitutional OwnershipPercentage31.37%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$115.70KNumber ofInstitutional Sellers(last 12 months)0 Get VIRX Insider Trade Alerts Want to know when executives and insiders are buying or selling Viracta Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Chart & View Institutional Buying and Selling Data VIRX Institutional Buying and Selling by Quarter Viracta Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails11/14/2024 Stonepine Capital Management LLC500,000$116K0.1%N/A1.268% 11/13/2023 Acadian Asset Management LLC97,109$99K0.0%-42.1%0.252% 8/7/2023 Acadian Asset Management LLC167,818$235K0.0%+74.6%0.436% 8/2/2023 MAI Capital Management307,570$434K0.0%-18.9%0.800% 7/20/2023 Bailard Inc.47,700$67K0.0%+139.7%0.124% 5/15/2023 Rubric Capital Management LP1,487,385$2.37M0.1%+11.8%3.872% 5/10/2023 MAI Capital Management379,468$603K0.0%-11.1%0.988% 5/8/2023 Bailard Inc.19,900$32K0.0%N/A0.052% 4/4/2023 Trust Co. of Toledo NA OH28,000$45K0.0%N/A0.073% 2/9/2023 MAI Capital Management426,916$623K0.0%-33.0%1.118% Get the Latest News and Ratings for VIRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Viracta Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 11/14/2022Ergoteles LLC132,636$566K0.0%-14.7%0.353% 11/14/2022 Rubric Capital Management LP994,801$4.25M0.2%N/A2.649% 11/8/2022 Hamilton Lane Advisors LLC35,791$153K0.1%-49.9%0.095% 8/15/2022 Laurion Capital Management LP698,000$2.71M0.0%N/A1.858% 8/12/2022 Ensign Peak Advisors Inc63,406$246K0.0%+4.8%0.169% 7/20/2022 Clear Harbor Asset Management LLC25,000$97K0.0%N/A0.067% 7/19/2022 MAI Capital Management647,950$2.51M0.0%+70.2%1.728% 5/11/2022Veritable L.P.24,836$118K0.0%N/A0.066% 5/10/2022 MAI Capital Management380,788$1.81M0.0%N/A1.016% 2/25/2022AlphaCentric Advisors LLC90,000$329K0.1%N/A0.241% 2/11/2022 Ensign Peak Advisors Inc60,515$221K0.0%N/A0.162% 2/8/2022 ProShare Advisors LLC13,174$49K0.0%N/A0.035% 2/8/2022 Northern Trust Corp293,492$1.07M0.0%-2.8%0.787% 1/28/2022 Allspring Global Investments Holdings LLC73,011$266K0.0%N/A0.196% 11/16/2021 Janus Henderson Group PLC249,686$2.00M0.0%-20.4%0.669% 11/16/2021 Metropolitan Life Insurance Co NY5,766$46K0.0%-48.8%0.015% 11/15/2021 Royal Bank of Canada182,319$1.46M0.0%-6.3%0.490% 11/15/2021 Franklin Resources Inc.43,618$350K0.0%N/A0.117% 11/15/2021 Jasper Ridge Partners L.P.92,939$745K0.0%N/A0.250% 11/12/2021 Jump Financial LLC21,852$175K0.0%N/A0.059% 11/12/2021 Oppenheimer & Co. Inc.38,037$305K0.0%N/A0.102% 11/12/2021 Geode Capital Management LLC481,301$3.86M0.0%+7.1%1.293% 11/10/2021 Goldman Sachs Group Inc.171,194$1.37M0.0%-34.5%0.460% 11/10/2021 Citigroup Inc.4,206$34K0.0%+109.6%0.011% 11/9/2021 Bourgeon Capital Management LLC18,750$150K0.0%+3,650.0%0.050% 11/9/2021BlackRock Inc.2,085,048$16.72M0.0%+1.2%5.600% 11/8/2021 State Board of Administration of Florida Retirement System10,068$81K0.0%N/A0.027% 11/5/2021 Advisor Group Holdings Inc.4,999$39K0.0%N/A0.013% 11/2/2021 New York State Common Retirement Fund22,055$177K0.0%-28.9%0.059% 11/1/2021 SG Americas Securities LLC20,454$164K0.0%N/A0.055% Trump’s national nightmare is here (Ad)Porter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger the biggest forced rotation of capital since World War II. They reveal why Trump is mobilizing America’s tech giants… and name the two stocks most likely to soar as trillions shift behind the scenes.Watch the National Emergency broadcast here10/22/2021 Spire Wealth Management3,698$30K0.0%-48.1%0.010% 10/14/2021 Hamilton Lane Advisors LLC71,491$573K0.1%N/A0.192% 8/17/2021 Samsara BioCapital LLC711,039$8.06M1.0%-14.5%1.917% 8/17/2021 Metropolitan Life Insurance Co NY11,260$128K0.0%N/A0.030% 8/17/2021 MetLife Investment Management LLC14,707$167K0.0%N/A0.040% 8/17/2021 Bridgeway Capital Management LLC50,000$567K0.0%N/A0.135% 8/16/2021 Opaleye Management Inc.257,189$2.92M0.5%+148.3%0.693% 8/16/2021 California State Teachers Retirement System49,982$567K0.0%N/A0.135% 8/16/2021 Kettle Hill Capital Management LLC185,065$2.10M0.4%N/A0.499% 8/16/2021 Royal Bank of Canada194,526$2.21M0.0%+9,426.2%0.524% 8/16/2021 Charles Schwab Investment Management Inc.83,792$951K0.0%N/A0.226% 8/16/2021 State Street Corp484,222$5.49M0.0%N/A1.305% 8/16/2021Nuveen Asset Management LLC147,734$1.68M0.0%N/A0.398% 8/16/2021 Goldman Sachs Group Inc.261,513$2.97M0.0%-56.7%0.705% 8/13/2021 Northern Trust Corp313,350$3.55M0.0%+2,273.5%0.845% 8/13/2021QS Investors LLC43,618$495K0.0%N/A0.118% 8/13/2021 Geode Capital Management LLC449,236$5.09M0.0%+667.5%1.211% 8/13/2021 Vanguard Group Inc.1,433,922$16.26M0.0%+589.2%3.866% 8/13/2021 Bailard Inc.145,000$1.64M0.1%+291.9%0.391% 8/12/2021 Trexquant Investment LP10,339$117K0.0%N/A0.028% 8/12/2021 Legal & General Group Plc3,098$35K0.0%N/A0.008% 8/12/2021 JPMorgan Chase & Co.13,919$158K0.0%N/A0.038% 8/12/2021 The Manufacturers Life Insurance Company21,875$248K0.0%N/A0.059% 8/11/2021 Bank of New York Mellon Corp98,295$1.12M0.0%N/A0.265% 8/11/2021BlackRock Inc.2,061,171$23.38M0.0%+1,006.2%5.557% 8/11/2021 Deutsche Bank AG21,524$244K0.0%N/A0.058% 8/6/2021 Ameritas Investment Partners Inc.2,843$32K0.0%N/A0.008% 8/6/2021 Nisa Investment Advisors LLC3,800$43K0.0%N/A0.010% 8/6/2021 Aisling Capital Management LP288,571$3.27M0.5%N/A0.778% 8/6/2021 Sei Investments Co.16,908$192K0.0%N/A0.046% 8/5/2021 Rhumbline Advisers30,082$341K0.0%N/A0.081% 8/2/2021 New York State Common Retirement Fund31,000$352K0.0%N/A0.084% (Data available from 1/1/2016 forward) VIRX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of VIRX shares? During the previous two years, the following institutional investors and hedge funds held shares of Viracta Therapeutics shares: Stonepine Capital Management LLC ($116K), Acadian Asset Management LLC ($99K).Learn more on Viracta Therapeutics' institutional investors. What percentage of Viracta Therapeutics' stock is owned by institutional investors? 31.37% of Viracta Therapeutics' stock is owned by institutional investors. Learn more on VIRX's institutional investor holdings. Which institutional investors have been buying Viracta Therapeutics' stock? The following institutional investors have purchased Viracta Therapeutics' stock in the last 24 months: Stonepine Capital Management LLC ($500K). How much institutional buying is happening at Viracta Therapeutics? Institutional investors have bought a total of 500,000 shares in the last 24 months. This purchase volume represents approximately $115.70K in transactions. Related Companies APVO Major Shareholders SHPH Major Shareholders ZVSA Major Shareholders PTPI Major Shareholders HEPA Major Shareholders VINC Major Shareholders NCNA Major Shareholders VRPX Major Shareholders NVS Major Shareholders This page (NASDAQ:VIRX) was last updated on 8/29/2025 by MarketBeat.com Staff From Our PartnersMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Viracta Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Viracta Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access